Clinical Trial Update: Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating weekly carboplatin and docetaxel for recurrent ovarian or primary peritoneal cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Carcinoma
• Peritoneal Carcinoma

Drugs mentioned

• carboplatin/docetaxel (carboplatin and docetaxel)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Ovarian Carcinoma, Primary Peritoneal Carcinoma | Phase 2 | Status: COMPLETED